SCHEMBL15902152

SCHEMBL15902152

COc1cc(NC(=O)c2cc(Cl)ccc2F)ccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.56
KCNMA1 Q12791 3/20 0.55
CNR1 P21554 1/20 0.49
GRM5 P41594 1/20 0.49
JAK2 O60674 1/20 0.48
JAK1 P23458 1/20 0.48
TYK2 P29597 1/20 0.48
NPC1 O15118 2/20 0.47
MAPT P10636 2/20 0.47
RAB9A P51151 2/20 0.47
GRM4 Q14833 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 1/20 0.47
P2RX1 P51575 1/20 0.47
SCN10A Q9Y5Y9 3/20 0.47
SCN8A Q9UQD0 1/20 0.47
TLR8 Q9NR97 1/20 0.46
KCNK3 O14649 1/20 0.46
KCNK9 Q9NPC2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15901905 0.91 SORT1 (0.57) SORT1KCNMA1CNR1JAK2JAK1
SCHEMBL15902028 0.89 SORT1 (0.57) SORT1CNR1GRM5NPC1MAPT
SCHEMBL15902067 0.86 SORT1 (0.55) SORT1CNR1JAK2JAK1TYK2
SCHEMBL15902246 0.84 SORT1 (0.78) SORT1JAK2JAK1TYK2NPC1
SCHEMBL15901799 0.82 SORT1 (0.56) SORT1NPC1RAB9AP2RX1SCN10A
SCHEMBL22941942 0.82 SORT1 (0.58) SORT1NPC1MAPTRAB9AGRM4
SCHEMBL15901896 0.79 SORT1 (0.57) SORT1NPC1MAPTRAB9AHPGD
SCHEMBL28921272 0.77 SORT1 (0.55) SORT1KCNMA1JAK2TYK2NPC1
SCHEMBL15901600 0.77 SORT1 (0.78) SORT1JAK2JAK1TYK2SCN10A
SCHEMBL15901610 0.76 KMT2A (0.54) SORT1MAPTSMN1; SMN2ALDH1A1SCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673864-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-06-13 US disclosed
EP-3865475-A1 PROCESS FOR PREPARING PYRIDONE AMIDES WHICH ARE MODULATORS OF SODIUM CHANNELS AND INTERMEDIATE COMPOUNDS USED THEREIN Vertex Pharmaceuticals Incorporated (US) 2021-08-18 EP disclosed
CN-108164457-B Pyridone amides as sodium channel modulators 沃泰克斯药物股份有限公司 2021-07-09 CN disclosed
US-20210047271-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2021-02-18 US disclosed
EP-3239134-B1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2020-12-23 EP disclosed
US-10738009-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-08-11 US disclosed
US-20190248745-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2019-08-15 US disclosed
US-10087143-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-10-02 US disclosed
US-20180016235-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2018-01-18 US disclosed
EP-3239134-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2017-11-01 EP disclosed
US-9758483-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-09-12 US disclosed
EP-2953931-B1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2017-03-01 EP disclosed
US-20170037009-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2017-02-09 US disclosed
US-9393235-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-07-19 US disclosed
EP-2953931-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2015-12-16 EP disclosed
US-20150246028-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2015-09-03 US disclosed
US-9051270-B2 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-06-09 US disclosed
WO-2014120808-A9 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PARMACEUTICALS INCORPORATED (US) 2015-05-14 WO disclosed
WO-2014120808-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PARMACEUTICALS INCORPORATED (US) 2014-08-07 WO disclosed
US-20140213616-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016235-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-20150246028-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-20140213616-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-10738009-B2 Pyridone amides as modulators of sodium channels SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-20170037009-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-20210047271-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-11673864-B2 Pyridone amides as modulators of sodium channels SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-10087143-B2 Pyridone amides as modulators of sodium channels SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885
US-20190248745-A1 PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS SCN5A, SCN1A, KCNJ2 SORT1 4300/4885KCNMA1 81/4885CNR1 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.